Stockscreener 앱 받기
4.51
0.22%
0.00
전일 마감가:
$4.51
열려 있는:
$4.42
하루 거래량:
119.27K
Relative Volume:
0.24
시가총액:
$574.93M
수익:
$253.52M
순이익/손실:
$-64.13M
주가수익비율:
-6.353
EPS:
-0.7099
순현금흐름:
-
1주 성능:
+7.36%
1개월 성능:
-1.09%
6개월 성능:
-0.22%
1년 성능:
-52.52%
1일 변동 폭
$4.40
$4.53
1주일 범위
$4.02
$4.578
52주 변동 폭
$3.28
$11.20
허싸이 그룹 ADR Stock (HSAI) Company Profile
HSAI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| HSAI | 4.51 | 574.93M | 253.52M | -64.13M | 0 | -0.7099 |
| GPC | 121.90 | 16.79B | 23.30B | 1.09B | 900.98M | 8.84 |
| MBLY | 16.86 | 13.72B | 1.80B | -2.96B | 214.00M | -0.08 |
| APTV | 52.80 | 12.36B | 19.73B | 2.42B | 1.14B | 8.00 |
| MGA | 43.11 | 12.21B | 42.66B | 1.08B | 889.00M | 3.61 |
| ALSN | 118.23 | 9.98B | 3.20B | 726.00M | 708.00M | 7.05 |
허싸이 그룹 ADR Stock (HSAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-03-13 | 개시 | Goldman | Buy |
| 2023-03-07 | 개시 | Credit Suisse | Outperform |
허싸이 그룹 ADR 주식(HSAI)의 최신 뉴스
Hesai Group to Report Third Quarter 2024 Financial Results on Monday, November 25, 2024 - GlobeNewswire Inc.
China's Hesai to press on with US lawsuit after being reinstated to blacklist By Reuters - Investing.com
Hesai Technology secures lidar deal with Leapmotor - Investing.com
Hesai Technology secures lidar deal with Leapmotor By Investing.com - Investing.com South Africa
Hesai returned to US list of firms alleged to help Beijing's military By Reuters - Investing.com
Hesai Group ADR (HSAI) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Quarterly Snapshot: Quick and Current Ratios for Hesai Group ADR (HSAI) - The Dwinnex
Is Hesai Group ADR (HSAI) a good investment opportunity? - US Post News
Healthy Upside Potential: Hesai Group ADR (HSAI) - SETE News
HSAI’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
Insider’s View: Deciphering Hesai Group ADR (HSAI)’s Financial Health Through Ratios - The Dwinnex
Hesai Group ADR Inc. (HSAI) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Hesai Group ADR (HSAI) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Analytical Lens: Exploring Hesai Group ADR (HSAI)’s Financial Story Through Ratios - The Dwinnex
Should investors be concerned about HSAI’s high price-to-sales ratio? - US Post News
Hesai, SAIC Volkswagen sign new partnership on automotive lidar program - TipRanks
Hesai Group ADR (HSAI) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Do investors need to be concerned about Hesai Group ADR (HSAI)? - US Post News
HSAI: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Top investors say Hesai Group ADR (HSAI) ticks everything they need - SETE News
Hesai Group ADR (HSAI)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Hesai Group ADR (HSAI) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Can you now get a good deal on Hesai Group ADR’s shares? - US Post News
Citi cuts Hesai Group stock target, maintains Buy rating - Investing.com India
Earnings call: Hesai Group maintains lead in LiDAR market, eyes profitability - Investing.com
Hesai Group’s Strong Q2 2024 Financial Results - TipRanks
Hesai reports Q2 EPS (RMB0.34) vs (RMB0.32) last year - TipRanks
Hesai Group ADR (HSAI) can make a big difference with a little luck - SETE News
Options Volatility and Implied Earnings Moves Today, August 19, 2024 - TipRanks
Taking the lead: Hesai Group ADR (HSAI) - SETE News
Can Hesai Group ADR (HSAI) meet market expectations this quarter? - US Post News
Hesai Group ADR (HSAI) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
BLZE underperforms with a -4.80 decrease in share price - US Post News
Was Gossamer Bio Inc (GOSS)’s session last reading good? - US Post News
What is the investor’s view on American Vanguard Corp. (AVD)? - US Post News
Should investors be concerned about Iterum Therapeutics Plc (ITRM)? - US Post News
Cogent Biosciences Inc (COGT) requires closer examination - US Post News
Examining 4D Molecular Therapeutics Inc (FDMT) stock is warranted - US Post News
A closer look at Kaixin Holdings. (KXIN) is warranted - US Post News
How did Big Lots Inc (BIG) fare last session? - US Post News
Is Celsius Holdings Inc (CELH) a threat to investors? - US Post News
OptiNose Inc (OPTN)’s stock rises to 0.91 per share - US Post News
How to interpret Oblong Inc (OBLG)’s stock chart patterns - US Post News
A year in review: Vuzix Corporation (VUZI)’s performance in the last year - US Post News
What is the investor’s view on Credo Technology Group Holding Ltd (CRDO)? - US Post News
Did Fate Therapeutics Inc (FATE) perform well in the last session? - US Post News
Beam Therapeutics Inc (BEAM) requires closer examination - US Post News
The Cardiff Oncology Inc (CRDF) had a good session last reading, didn’t it? - US Post News
VNET Group Inc ADR (VNET) did well last session? - US Post News
Verona Pharma Plc ADR (VRNA)’s stock price in review: A technical analysis - US Post News
Amarin Corp ADR (AMRN) stock on the rise: An overview - US Post News
허싸이 그룹 ADR (HSAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.01%
0.24%
자본화:
|
볼륨(24시간):